The documents, presented in Israel last month to officials from the Departments of State and Defense, raise concerns ...
David Trick stated, "Adjusted EBITDA from continuing operations to stockholders was a loss of $3 million compared to a sub $2 ...
Q3 2025 Earnings Call November 11, 2025 3:00 AM ESTCompany ParticipantsStephan Gramkow - Head of Investor RelationsAndreas ...
Detailed price information for Claritev Corporation (CTEV-N) from The Globe and Mail including charting and trades.
Discover the art of traditional craftsmanship as we take you through the fascinating process of making a cow bullock cart ...
Dubai International Airport (DXB) is ultimately where the Emirates ground game shines. The business class lounges span long ...
Q3 2025 Earnings Call November 10, 2025 8:30 AM ESTCompany ParticipantsKate Rausch - Head of Investor RelationsPaul Bolno ...
Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the third quarter of 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback